Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Mark"

5723 News Found

Glenmark Pharma appoints Shisher Chowksey as Head of Marketing
People | May 27, 2026

Glenmark Pharma appoints Shisher Chowksey as Head of Marketing

In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth


Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
Medical Device | May 26, 2026

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery


Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
interviews | May 25, 2026

Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.


Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
interviews | May 25, 2026

Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Nexis GC-2060 replaces legacy baselines by introducing advanced automated workflows, expanded modularity, and enhanced detector sensitivity designed to minimize laboratory downtime


Lupin enters China market with approval for Oseltamivir oral suspension
Drug Approval | May 22, 2026

Lupin enters China market with approval for Oseltamivir oral suspension

The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment


HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin
Healthcare | May 19, 2026

HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin

Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development


Zeus Hygia launches Metaberine in Europe and US markets
Healthcare | May 19, 2026

Zeus Hygia launches Metaberine in Europe and US markets

Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management


Glenmark Pharma introduces Vancomycin Injection in U.S. market
News | May 18, 2026

Glenmark Pharma introduces Vancomycin Injection in U.S. market

The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.


WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med
News | May 16, 2026

WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med

The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers


Pfizer scores landmark EU approval for  hemophilia drug HYMPAVZI
Drug Approval | May 14, 2026

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy